Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
- Roehrborn CG, Barkin J, Gange SN, et al. Five year results of the prospective randomized controlled prostatic urethral L.I.F.T. study. Can J Urol. 2017;24(3):8802-8813.
- Porpiglia F, Fiori C, Bertolo R, et al. Temporary implantable nitinol device (TIND): a novel, minimally invasive treatment for relief of lower urinary tract symptoms (LUTS) related to benign prostatic hyperplasia (BPH): feasibility, safety and functional results at 1 year of follow-up. BJU Int. 2015;116(2):278-287.
- Roehrborn CG, Gilling P. The Water Study clinical results – A phase III blinded randomized parallel group trial of Aquablation vs transurethral resection of the prostate with blinded outcome assessment for moderate-to-severe LUTS in men with benign prostatic hyperplasia. Paper presented at: 2017 AUA Annual Meeting; May 12-16, 2017; Boston, Massachusetts. Abstract PNFLBA-03. J Urol. 2017;197(suppl 4): e603-e604.
- McVary KT, Roehrborn CG. Three-year outcomes of the prospective, randomized controlled Rezūm system study: Convective radiofrequency thermal therapy for treatment of lower urinary tract symptoms due to benign prostatic hyperplasia. Urology. 2017 Nov 6. [Epub ahead of print]
Disclosure statements are available on the authors' profiles: